nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminophylline—CYP3A4—bone cancer	0.733	1	CbGaD
Aminophylline—Venous thrombosis—Carboplatin—bone cancer	0.0106	0.0657	CcSEcCtD
Aminophylline—Fluid overload—Carboplatin—bone cancer	0.00918	0.057	CcSEcCtD
Aminophylline—Extravasation—Carboplatin—bone cancer	0.00654	0.0406	CcSEcCtD
Aminophylline—Diuresis—Cisplatin—bone cancer	0.0054	0.0335	CcSEcCtD
Aminophylline—Phlebitis—Carboplatin—bone cancer	0.00481	0.0299	CcSEcCtD
Aminophylline—Skin necrosis—Cisplatin—bone cancer	0.00479	0.0298	CcSEcCtD
Aminophylline—Bronchial hyperreactivity—Methotrexate—bone cancer	0.00352	0.0219	CcSEcCtD
Aminophylline—Chronic obstructive pulmonary disease—Methotrexate—bone cancer	0.00321	0.02	CcSEcCtD
Aminophylline—Venous thrombosis—Cisplatin—bone cancer	0.0031	0.0193	CcSEcCtD
Aminophylline—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.00288	0.0179	CcSEcCtD
Aminophylline—Fluid overload—Cisplatin—bone cancer	0.00269	0.0167	CcSEcCtD
Aminophylline—Skin necrosis—Methotrexate—bone cancer	0.00263	0.0163	CcSEcCtD
Aminophylline—Skin necrosis—Epirubicin—bone cancer	0.00246	0.0153	CcSEcCtD
Aminophylline—Skin necrosis—Doxorubicin—bone cancer	0.00228	0.0141	CcSEcCtD
Aminophylline—Sinus tachycardia—Epirubicin—bone cancer	0.00213	0.0133	CcSEcCtD
Aminophylline—Infection—Carboplatin—bone cancer	0.00202	0.0126	CcSEcCtD
Aminophylline—Sinus tachycardia—Doxorubicin—bone cancer	0.00197	0.0123	CcSEcCtD
Aminophylline—Extravasation—Cisplatin—bone cancer	0.00192	0.0119	CcSEcCtD
Aminophylline—Hyperuricaemia—Cisplatin—bone cancer	0.0018	0.0112	CcSEcCtD
Aminophylline—Blood uric acid increased—Cisplatin—bone cancer	0.0017	0.0106	CcSEcCtD
Aminophylline—Body temperature increased—Carboplatin—bone cancer	0.00161	0.01	CcSEcCtD
Aminophylline—Skin exfoliation—Cisplatin—bone cancer	0.0016	0.00993	CcSEcCtD
Aminophylline—Venous thrombosis—Epirubicin—bone cancer	0.00159	0.00989	CcSEcCtD
Aminophylline—Venous thrombosis—Doxorubicin—bone cancer	0.00147	0.00915	CcSEcCtD
Aminophylline—Phlebitis—Cisplatin—bone cancer	0.00141	0.00876	CcSEcCtD
Aminophylline—Polyuria—Cisplatin—bone cancer	0.00138	0.0086	CcSEcCtD
Aminophylline—Haematemesis—Methotrexate—bone cancer	0.00132	0.00821	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Cisplatin—bone cancer	0.00126	0.0078	CcSEcCtD
Aminophylline—Haematemesis—Epirubicin—bone cancer	0.00124	0.00769	CcSEcCtD
Aminophylline—Hypercalcaemia—Epirubicin—bone cancer	0.00124	0.00769	CcSEcCtD
Aminophylline—Ventricular arrhythmia—Epirubicin—bone cancer	0.00116	0.00722	CcSEcCtD
Aminophylline—Irritability—Cisplatin—bone cancer	0.00116	0.0072	CcSEcCtD
Aminophylline—Albuminuria—Epirubicin—bone cancer	0.00115	0.00715	CcSEcCtD
Aminophylline—Hypercalcaemia—Doxorubicin—bone cancer	0.00114	0.00711	CcSEcCtD
Aminophylline—Haematemesis—Doxorubicin—bone cancer	0.00114	0.00711	CcSEcCtD
Aminophylline—Hypokalaemia—Cisplatin—bone cancer	0.00111	0.00687	CcSEcCtD
Aminophylline—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00107	0.00668	CcSEcCtD
Aminophylline—Albuminuria—Doxorubicin—bone cancer	0.00107	0.00662	CcSEcCtD
Aminophylline—Extravasation—Methotrexate—bone cancer	0.00105	0.00654	CcSEcCtD
Aminophylline—Theophylline—CYP3A4—bone cancer	0.00103	1	CrCbGaD
Aminophylline—Hyperuricaemia—Methotrexate—bone cancer	0.00099	0.00615	CcSEcCtD
Aminophylline—Extravasation—Epirubicin—bone cancer	0.000985	0.00612	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Epirubicin—bone cancer	0.000952	0.00591	CcSEcCtD
Aminophylline—Blood uric acid increased—Methotrexate—bone cancer	0.000935	0.00581	CcSEcCtD
Aminophylline—Hyperuricaemia—Epirubicin—bone cancer	0.000927	0.00576	CcSEcCtD
Aminophylline—Extravasation—Doxorubicin—bone cancer	0.000912	0.00566	CcSEcCtD
Aminophylline—Ventricular extrasystoles—Doxorubicin—bone cancer	0.000881	0.00547	CcSEcCtD
Aminophylline—Skin exfoliation—Methotrexate—bone cancer	0.000877	0.00545	CcSEcCtD
Aminophylline—Blood uric acid increased—Epirubicin—bone cancer	0.000875	0.00544	CcSEcCtD
Aminophylline—Hyperuricaemia—Doxorubicin—bone cancer	0.000857	0.00533	CcSEcCtD
Aminophylline—Dermatitis contact—Epirubicin—bone cancer	0.00085	0.00528	CcSEcCtD
Aminophylline—Coma—Methotrexate—bone cancer	0.000839	0.00521	CcSEcCtD
Aminophylline—Skin exfoliation—Epirubicin—bone cancer	0.000821	0.0051	CcSEcCtD
Aminophylline—Blood uric acid increased—Doxorubicin—bone cancer	0.00081	0.00503	CcSEcCtD
Aminophylline—Dermatitis contact—Doxorubicin—bone cancer	0.000786	0.00488	CcSEcCtD
Aminophylline—Coma—Epirubicin—bone cancer	0.000786	0.00488	CcSEcCtD
Aminophylline—Flushing—Cisplatin—bone cancer	0.00078	0.00485	CcSEcCtD
Aminophylline—Polyuria—Methotrexate—bone cancer	0.000759	0.00472	CcSEcCtD
Aminophylline—Skin exfoliation—Doxorubicin—bone cancer	0.000759	0.00472	CcSEcCtD
Aminophylline—Arrhythmia—Cisplatin—bone cancer	0.000751	0.00467	CcSEcCtD
Aminophylline—Alopecia—Cisplatin—bone cancer	0.000743	0.00461	CcSEcCtD
Aminophylline—Coma—Doxorubicin—bone cancer	0.000727	0.00452	CcSEcCtD
Aminophylline—Phlebitis—Epirubicin—bone cancer	0.000724	0.0045	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Methotrexate—bone cancer	0.000707	0.00439	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Methotrexate—bone cancer	0.000689	0.00428	CcSEcCtD
Aminophylline—Tremor—Cisplatin—bone cancer	0.000686	0.00426	CcSEcCtD
Aminophylline—Phlebitis—Doxorubicin—bone cancer	0.00067	0.00416	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Epirubicin—bone cancer	0.000661	0.00411	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Epirubicin—bone cancer	0.000645	0.00401	CcSEcCtD
Aminophylline—Irritability—Methotrexate—bone cancer	0.000636	0.00395	CcSEcCtD
Aminophylline—Convulsion—Cisplatin—bone cancer	0.000634	0.00394	CcSEcCtD
Aminophylline—Anxiety—Cisplatin—bone cancer	0.000621	0.00386	CcSEcCtD
Aminophylline—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000612	0.0038	CcSEcCtD
Aminophylline—Anaphylactic shock—Cisplatin—bone cancer	0.000597	0.00371	CcSEcCtD
Aminophylline—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000597	0.00371	CcSEcCtD
Aminophylline—Infection—Cisplatin—bone cancer	0.000593	0.00369	CcSEcCtD
Aminophylline—Nervous system disorder—Cisplatin—bone cancer	0.000586	0.00364	CcSEcCtD
Aminophylline—Tachycardia—Cisplatin—bone cancer	0.000583	0.00362	CcSEcCtD
Aminophylline—Abdominal pain upper—Epirubicin—bone cancer	0.00057	0.00354	CcSEcCtD
Aminophylline—Anorexia—Cisplatin—bone cancer	0.000569	0.00354	CcSEcCtD
Aminophylline—Hypokalaemia—Epirubicin—bone cancer	0.000568	0.00353	CcSEcCtD
Aminophylline—Hypotension—Cisplatin—bone cancer	0.000558	0.00347	CcSEcCtD
Aminophylline—Abdominal pain upper—Doxorubicin—bone cancer	0.000527	0.00328	CcSEcCtD
Aminophylline—Hypokalaemia—Doxorubicin—bone cancer	0.000525	0.00326	CcSEcCtD
Aminophylline—Decreased appetite—Cisplatin—bone cancer	0.000519	0.00323	CcSEcCtD
Aminophylline—Haematuria—Methotrexate—bone cancer	0.00049	0.00304	CcSEcCtD
Aminophylline—Hyperglycaemia—Epirubicin—bone cancer	0.000487	0.00302	CcSEcCtD
Aminophylline—Body temperature increased—Cisplatin—bone cancer	0.000472	0.00293	CcSEcCtD
Aminophylline—Haematuria—Epirubicin—bone cancer	0.000459	0.00285	CcSEcCtD
Aminophylline—Hyperglycaemia—Doxorubicin—bone cancer	0.00045	0.0028	CcSEcCtD
Aminophylline—Hypersensitivity—Cisplatin—bone cancer	0.00044	0.00273	CcSEcCtD
Aminophylline—Haematuria—Doxorubicin—bone cancer	0.000424	0.00264	CcSEcCtD
Aminophylline—Diarrhoea—Cisplatin—bone cancer	0.000409	0.00254	CcSEcCtD
Aminophylline—Alopecia—Methotrexate—bone cancer	0.000408	0.00253	CcSEcCtD
Aminophylline—Flushing—Epirubicin—bone cancer	0.000401	0.00249	CcSEcCtD
Aminophylline—Arrhythmia—Epirubicin—bone cancer	0.000386	0.0024	CcSEcCtD
Aminophylline—Alopecia—Epirubicin—bone cancer	0.000381	0.00237	CcSEcCtD
Aminophylline—Vomiting—Cisplatin—bone cancer	0.00038	0.00236	CcSEcCtD
Aminophylline—Rash—Cisplatin—bone cancer	0.000377	0.00234	CcSEcCtD
Aminophylline—Dermatitis—Cisplatin—bone cancer	0.000376	0.00234	CcSEcCtD
Aminophylline—Flushing—Doxorubicin—bone cancer	0.000371	0.0023	CcSEcCtD
Aminophylline—Tension—Epirubicin—bone cancer	0.000369	0.00229	CcSEcCtD
Aminophylline—Nervousness—Epirubicin—bone cancer	0.000365	0.00227	CcSEcCtD
Aminophylline—Arrhythmia—Doxorubicin—bone cancer	0.000357	0.00222	CcSEcCtD
Aminophylline—Nausea—Cisplatin—bone cancer	0.000355	0.0022	CcSEcCtD
Aminophylline—Alopecia—Doxorubicin—bone cancer	0.000353	0.00219	CcSEcCtD
Aminophylline—Convulsion—Methotrexate—bone cancer	0.000348	0.00216	CcSEcCtD
Aminophylline—Agitation—Epirubicin—bone cancer	0.000345	0.00215	CcSEcCtD
Aminophylline—Tension—Doxorubicin—bone cancer	0.000341	0.00212	CcSEcCtD
Aminophylline—Nervousness—Doxorubicin—bone cancer	0.000338	0.0021	CcSEcCtD
Aminophylline—Palpitations—Epirubicin—bone cancer	0.000332	0.00206	CcSEcCtD
Aminophylline—Anaphylactic shock—Methotrexate—bone cancer	0.000328	0.00204	CcSEcCtD
Aminophylline—Convulsion—Epirubicin—bone cancer	0.000326	0.00202	CcSEcCtD
Aminophylline—Infection—Methotrexate—bone cancer	0.000326	0.00202	CcSEcCtD
Aminophylline—Nervous system disorder—Methotrexate—bone cancer	0.000321	0.002	CcSEcCtD
Aminophylline—Agitation—Doxorubicin—bone cancer	0.00032	0.00199	CcSEcCtD
Aminophylline—Anxiety—Epirubicin—bone cancer	0.000319	0.00198	CcSEcCtD
Aminophylline—Anorexia—Methotrexate—bone cancer	0.000312	0.00194	CcSEcCtD
Aminophylline—Palpitations—Doxorubicin—bone cancer	0.000307	0.00191	CcSEcCtD
Aminophylline—Anaphylactic shock—Epirubicin—bone cancer	0.000307	0.00191	CcSEcCtD
Aminophylline—Hypotension—Methotrexate—bone cancer	0.000306	0.0019	CcSEcCtD
Aminophylline—Infection—Epirubicin—bone cancer	0.000305	0.00189	CcSEcCtD
Aminophylline—Shock—Epirubicin—bone cancer	0.000302	0.00187	CcSEcCtD
Aminophylline—Convulsion—Doxorubicin—bone cancer	0.000301	0.00187	CcSEcCtD
Aminophylline—Nervous system disorder—Epirubicin—bone cancer	0.000301	0.00187	CcSEcCtD
Aminophylline—Tachycardia—Epirubicin—bone cancer	0.000299	0.00186	CcSEcCtD
Aminophylline—Insomnia—Methotrexate—bone cancer	0.000296	0.00184	CcSEcCtD
Aminophylline—Anxiety—Doxorubicin—bone cancer	0.000295	0.00183	CcSEcCtD
Aminophylline—Anorexia—Epirubicin—bone cancer	0.000292	0.00182	CcSEcCtD
Aminophylline—Dyspepsia—Methotrexate—bone cancer	0.000288	0.00179	CcSEcCtD
Aminophylline—Hypotension—Epirubicin—bone cancer	0.000287	0.00178	CcSEcCtD
Aminophylline—PDE3A—Hemostasis—SPARC—bone cancer	0.000285	0.00271	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—RB1—bone cancer	0.000285	0.0027	CbGpPWpGaD
Aminophylline—Decreased appetite—Methotrexate—bone cancer	0.000285	0.00177	CcSEcCtD
Aminophylline—ADORA2A—Signaling by NGF—ATF1—bone cancer	0.000285	0.0027	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—GRM4—bone cancer	0.000284	0.0027	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—RGS1—bone cancer	0.000284	0.0027	CbGpPWpGaD
Aminophylline—Anaphylactic shock—Doxorubicin—bone cancer	0.000284	0.00176	CcSEcCtD
Aminophylline—Infection—Doxorubicin—bone cancer	0.000282	0.00175	CcSEcCtD
Aminophylline—Shock—Doxorubicin—bone cancer	0.000279	0.00173	CcSEcCtD
Aminophylline—Nervous system disorder—Doxorubicin—bone cancer	0.000278	0.00173	CcSEcCtD
Aminophylline—Insomnia—Epirubicin—bone cancer	0.000277	0.00172	CcSEcCtD
Aminophylline—Tachycardia—Doxorubicin—bone cancer	0.000277	0.00172	CcSEcCtD
Aminophylline—PDE4A—Signaling by GPCR—RGS1—bone cancer	0.000276	0.00261	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—GRM4—bone cancer	0.000276	0.00261	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—MMP2—bone cancer	0.000274	0.00259	CbGpPWpGaD
Aminophylline—Anorexia—Doxorubicin—bone cancer	0.000271	0.00168	CcSEcCtD
Aminophylline—Dyspepsia—Epirubicin—bone cancer	0.00027	0.00168	CcSEcCtD
Aminophylline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000269	0.00255	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—RGS1—bone cancer	0.000268	0.00254	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—GRM4—bone cancer	0.000268	0.00254	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Methotrexate—bone cancer	0.000268	0.00166	CcSEcCtD
Aminophylline—Decreased appetite—Epirubicin—bone cancer	0.000267	0.00166	CcSEcCtD
Aminophylline—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000265	0.00252	CbGpPWpGaD
Aminophylline—Hypotension—Doxorubicin—bone cancer	0.000265	0.00165	CcSEcCtD
Aminophylline—ADORA2B—Signaling by GPCR—GRM1—bone cancer	0.000263	0.0025	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—GRM1—bone cancer	0.000263	0.0025	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—GNA11—bone cancer	0.000261	0.00248	CbGpPWpGaD
Aminophylline—Urticaria—Methotrexate—bone cancer	0.00026	0.00162	CcSEcCtD
Aminophylline—Body temperature increased—Methotrexate—bone cancer	0.000259	0.00161	CcSEcCtD
Aminophylline—Abdominal pain—Methotrexate—bone cancer	0.000259	0.00161	CcSEcCtD
Aminophylline—HDAC2—Signaling by NOTCH—JUN—bone cancer	0.000258	0.00245	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—RGS1—bone cancer	0.000258	0.00245	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—GRM4—bone cancer	0.000258	0.00245	CbGpPWpGaD
Aminophylline—Insomnia—Doxorubicin—bone cancer	0.000257	0.00159	CcSEcCtD
Aminophylline—PDE3A—GPCR downstream signaling—GRM1—bone cancer	0.000256	0.00243	CbGpPWpGaD
Aminophylline—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000254	0.00241	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Epirubicin—bone cancer	0.000251	0.00156	CcSEcCtD
Aminophylline—Dyspepsia—Doxorubicin—bone cancer	0.00025	0.00155	CcSEcCtD
Aminophylline—Decreased appetite—Doxorubicin—bone cancer	0.000247	0.00153	CcSEcCtD
Aminophylline—ADORA1—GPCR downstream signaling—GRM1—bone cancer	0.000246	0.00234	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—CDK4—bone cancer	0.000246	0.00233	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—FUS—bone cancer	0.000244	0.00231	CbGpPWpGaD
Aminophylline—Urticaria—Epirubicin—bone cancer	0.000244	0.00151	CcSEcCtD
Aminophylline—HDAC2—Direct p53 effectors—MDM2—bone cancer	0.000243	0.00231	CbGpPWpGaD
Aminophylline—Abdominal pain—Epirubicin—bone cancer	0.000242	0.00151	CcSEcCtD
Aminophylline—Body temperature increased—Epirubicin—bone cancer	0.000242	0.00151	CcSEcCtD
Aminophylline—Hypersensitivity—Methotrexate—bone cancer	0.000241	0.0015	CcSEcCtD
Aminophylline—PDE4A—Signaling by GPCR—GRM1—bone cancer	0.000239	0.00227	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR ligand binding—SMO—bone cancer	0.000237	0.00225	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—IL3—bone cancer	0.000237	0.00225	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—GRM1—bone cancer	0.000233	0.00221	CbGpPWpGaD
Aminophylline—Gastrointestinal pain—Doxorubicin—bone cancer	0.000232	0.00144	CcSEcCtD
Aminophylline—Pruritus—Methotrexate—bone cancer	0.000232	0.00144	CcSEcCtD
Aminophylline—HDAC2—Chromatin modifying enzymes—CDK4—bone cancer	0.000231	0.00219	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—CDK4—bone cancer	0.000228	0.00217	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—SPARC—bone cancer	0.000228	0.00216	CbGpPWpGaD
Aminophylline—Hypersensitivity—Epirubicin—bone cancer	0.000226	0.0014	CcSEcCtD
Aminophylline—Urticaria—Doxorubicin—bone cancer	0.000225	0.0014	CcSEcCtD
Aminophylline—Body temperature increased—Doxorubicin—bone cancer	0.000224	0.00139	CcSEcCtD
Aminophylline—Abdominal pain—Doxorubicin—bone cancer	0.000224	0.00139	CcSEcCtD
Aminophylline—Diarrhoea—Methotrexate—bone cancer	0.000224	0.00139	CcSEcCtD
Aminophylline—ADORA1—Signaling by GPCR—GRM1—bone cancer	0.000224	0.00212	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—GRM4—bone cancer	0.000219	0.00208	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—RGS1—bone cancer	0.000219	0.00208	CbGpPWpGaD
Aminophylline—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000218	0.00207	CbGpPWpGaD
Aminophylline—Pruritus—Epirubicin—bone cancer	0.000217	0.00135	CcSEcCtD
Aminophylline—Dizziness—Methotrexate—bone cancer	0.000217	0.00135	CcSEcCtD
Aminophylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000214	0.00203	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—JUN—bone cancer	0.000211	0.002	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000211	0.002	CbGpPWpGaD
Aminophylline—Diarrhoea—Epirubicin—bone cancer	0.00021	0.0013	CcSEcCtD
Aminophylline—Hypersensitivity—Doxorubicin—bone cancer	0.000209	0.0013	CcSEcCtD
Aminophylline—HDAC2—Hemostasis—GNA11—bone cancer	0.000209	0.00198	CbGpPWpGaD
Aminophylline—Vomiting—Methotrexate—bone cancer	0.000208	0.00129	CcSEcCtD
Aminophylline—Rash—Methotrexate—bone cancer	0.000207	0.00128	CcSEcCtD
Aminophylline—Dermatitis—Methotrexate—bone cancer	0.000206	0.00128	CcSEcCtD
Aminophylline—Headache—Methotrexate—bone cancer	0.000205	0.00128	CcSEcCtD
Aminophylline—Dizziness—Epirubicin—bone cancer	0.000203	0.00126	CcSEcCtD
Aminophylline—Pruritus—Doxorubicin—bone cancer	0.000201	0.00125	CcSEcCtD
Aminophylline—ADORA2A—Signaling by GPCR—RGS1—bone cancer	0.000199	0.00189	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—GRM4—bone cancer	0.000199	0.00189	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000198	0.00188	CbGpPWpGaD
Aminophylline—Vomiting—Epirubicin—bone cancer	0.000195	0.00121	CcSEcCtD
Aminophylline—Nausea—Methotrexate—bone cancer	0.000195	0.00121	CcSEcCtD
Aminophylline—Diarrhoea—Doxorubicin—bone cancer	0.000194	0.00121	CcSEcCtD
Aminophylline—Rash—Epirubicin—bone cancer	0.000193	0.0012	CcSEcCtD
Aminophylline—Dermatitis—Epirubicin—bone cancer	0.000193	0.0012	CcSEcCtD
Aminophylline—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000193	0.00183	CbGpPWpGaD
Aminophylline—Headache—Epirubicin—bone cancer	0.000192	0.00119	CcSEcCtD
Aminophylline—ADORA1—Circadian rythm related genes—JUN—bone cancer	0.000191	0.00181	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—GRM1—bone cancer	0.00019	0.00181	CbGpPWpGaD
Aminophylline—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00019	0.0018	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—IL3—bone cancer	0.000189	0.00179	CbGpPWpGaD
Aminophylline—Dizziness—Doxorubicin—bone cancer	0.000188	0.00117	CcSEcCtD
Aminophylline—ADORA2B—GPCR downstream signaling—GNA11—bone cancer	0.000187	0.00177	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—SMO—bone cancer	0.000185	0.00176	CbGpPWpGaD
Aminophylline—Nausea—Epirubicin—bone cancer	0.000182	0.00113	CcSEcCtD
Aminophylline—Vomiting—Doxorubicin—bone cancer	0.00018	0.00112	CcSEcCtD
Aminophylline—HDAC2—Cell Cycle—TP53—bone cancer	0.00018	0.0017	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—GRM4—bone cancer	0.000179	0.0017	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—RGS1—bone cancer	0.000179	0.0017	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000179	0.0017	CbGpPWpGaD
Aminophylline—Rash—Doxorubicin—bone cancer	0.000179	0.00111	CcSEcCtD
Aminophylline—Dermatitis—Doxorubicin—bone cancer	0.000179	0.00111	CcSEcCtD
Aminophylline—Headache—Doxorubicin—bone cancer	0.000178	0.0011	CcSEcCtD
Aminophylline—HDAC2—Signaling by NGF—KIT—bone cancer	0.000174	0.00165	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—GRM1—bone cancer	0.000173	0.00164	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NOTCH—TP53—bone cancer	0.00017	0.00162	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—GNA11—bone cancer	0.00017	0.00161	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—GNA11—bone cancer	0.00017	0.00161	CbGpPWpGaD
Aminophylline—ADORA2B—GPCR downstream signaling—IL3—bone cancer	0.000169	0.00161	CbGpPWpGaD
Aminophylline—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000169	0.00161	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—NR1I2—bone cancer	0.000169	0.0016	CbGpPWpGaD
Aminophylline—Nausea—Doxorubicin—bone cancer	0.000169	0.00105	CcSEcCtD
Aminophylline—PDE4A—Signaling by GPCR—SMO—bone cancer	0.000168	0.0016	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—EGFR—bone cancer	0.000166	0.00158	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000166	0.00157	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—GNA11—bone cancer	0.000165	0.00157	CbGpPWpGaD
Aminophylline—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000165	0.00156	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—BRAF—bone cancer	0.000164	0.00155	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—SMO—bone cancer	0.000164	0.00155	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—RGS1—bone cancer	0.000163	0.00154	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—GRM4—bone cancer	0.000163	0.00154	CbGpPWpGaD
Aminophylline—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000162	0.00154	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—KIT—bone cancer	0.000162	0.00154	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—GNA11—bone cancer	0.000159	0.00151	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—GRM4—bone cancer	0.000158	0.0015	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—RGS1—bone cancer	0.000158	0.0015	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—JUN—bone cancer	0.000158	0.0015	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—SMO—bone cancer	0.000158	0.0015	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—GRM1—bone cancer	0.000156	0.00147	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—PLAU—bone cancer	0.000155	0.00147	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—GNA11—bone cancer	0.000154	0.00146	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—IL3—bone cancer	0.000154	0.00146	CbGpPWpGaD
Aminophylline—PDE4A—GPCR downstream signaling—IL3—bone cancer	0.000154	0.00146	CbGpPWpGaD
Aminophylline—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000153	0.00145	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—RGS1—bone cancer	0.000153	0.00145	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—GRM4—bone cancer	0.000153	0.00145	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—BRAF—bone cancer	0.000152	0.00144	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—GNA11—bone cancer	0.00015	0.00142	CbGpPWpGaD
Aminophylline—PDE3A—GPCR downstream signaling—IL3—bone cancer	0.00015	0.00142	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000147	0.0014	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—JUN—bone cancer	0.000147	0.0014	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—GNA11—bone cancer	0.000144	0.00137	CbGpPWpGaD
Aminophylline—ADORA1—GPCR downstream signaling—IL3—bone cancer	0.000144	0.00137	CbGpPWpGaD
Aminophylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—bone cancer	0.000143	0.00135	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—GRM1—bone cancer	0.000141	0.00134	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—IL3—bone cancer	0.00014	0.00132	CbGpPWpGaD
Aminophylline—HDAC2—Direct p53 effectors—TP53—bone cancer	0.000139	0.00132	CbGpPWpGaD
Aminophylline—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000138	0.00131	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—GRM1—bone cancer	0.000137	0.0013	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—MDM2—bone cancer	0.000137	0.0013	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—IL3—bone cancer	0.000136	0.00129	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000133	0.00126	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—GRM1—bone cancer	0.000132	0.00125	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—IL3—bone cancer	0.000131	0.00124	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—MDM2—bone cancer	0.000128	0.00121	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—RGS1—bone cancer	0.000127	0.0012	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GRM4—bone cancer	0.000127	0.0012	CbGpPWpGaD
Aminophylline—ADORA1—Circadian rythm related genes—TP53—bone cancer	0.000126	0.00119	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—EIF2S1—bone cancer	0.000125	0.00118	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—PLAU—bone cancer	0.000124	0.00118	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—GNA11—bone cancer	0.000123	0.00116	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—SMO—bone cancer	0.000122	0.00115	CbGpPWpGaD
Aminophylline—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000118	0.00112	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GRM4—bone cancer	0.000118	0.00112	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—RGS1—bone cancer	0.000118	0.00112	CbGpPWpGaD
Aminophylline—HDAC2—Disease—ENO2—bone cancer	0.000117	0.00111	CbGpPWpGaD
Aminophylline—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000116	0.0011	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000115	0.00109	CbGpPWpGaD
Aminophylline—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000114	0.00108	CbGpPWpGaD
Aminophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000113	0.00108	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—GNA11—bone cancer	0.000111	0.00106	CbGpPWpGaD
Aminophylline—ADORA2A—GPCR downstream signaling—IL3—bone cancer	0.000111	0.00105	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GRM1—bone cancer	0.00011	0.00104	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—SMO—bone cancer	0.00011	0.00104	CbGpPWpGaD
Aminophylline—HDAC2—Gene Expression—EZH2—bone cancer	0.000108	0.00103	CbGpPWpGaD
Aminophylline—HDAC2—Disease—DHFR—bone cancer	0.000108	0.00103	CbGpPWpGaD
Aminophylline—HDAC2—Circadian rythm related genes—TP53—bone cancer	0.000104	0.000991	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000104	0.00099	CbGpPWpGaD
Aminophylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000104	0.00099	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GRM1—bone cancer	0.000102	0.000968	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—IL3—bone cancer	0.000101	0.000958	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—GNA11—bone cancer	0.0001	0.00095	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—SMO—bone cancer	9.95e-05	0.000944	CbGpPWpGaD
Aminophylline—CYP1A2—Biological oxidations—GSTP1—bone cancer	9.9e-05	0.000939	CbGpPWpGaD
Aminophylline—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	9.76e-05	0.000926	CbGpPWpGaD
Aminophylline—ADORA2A—Circadian rythm related genes—TP53—bone cancer	9.71e-05	0.000921	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—SMO—bone cancer	9.68e-05	0.000918	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—NT5C3A—bone cancer	9.56e-05	0.000907	CbGpPWpGaD
Aminophylline—HDAC2—Signaling by NGF—EGFR—bone cancer	9.38e-05	0.00089	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—SMO—bone cancer	9.32e-05	0.000884	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—ATF1—bone cancer	9.32e-05	0.000884	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—GNA11—bone cancer	9.1e-05	0.000863	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IL3—bone cancer	9.09e-05	0.000862	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—GNA11—bone cancer	8.85e-05	0.00084	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by NGF—EGFR—bone cancer	8.72e-05	0.000827	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—GNA11—bone cancer	8.52e-05	0.000808	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—ATF1—bone cancer	8.46e-05	0.000802	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IL3—bone cancer	8.25e-05	0.000782	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—ATF1—bone cancer	8.23e-05	0.000781	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IL3—bone cancer	8.03e-05	0.000761	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—ATF1—bone cancer	7.92e-05	0.000751	CbGpPWpGaD
Aminophylline—HDAC2—Disease—TGFBR2—bone cancer	7.84e-05	0.000743	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TGFBR2—bone cancer	7.77e-05	0.000737	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—SMO—bone cancer	7.74e-05	0.000734	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IL3—bone cancer	7.73e-05	0.000733	CbGpPWpGaD
Aminophylline—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.64e-05	0.000725	CbGpPWpGaD
Aminophylline—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.54e-05	0.000715	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—IGF1R—bone cancer	7.31e-05	0.000693	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—SMO—bone cancer	7.19e-05	0.000682	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—GNA11—bone cancer	7.08e-05	0.000671	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TGFBR2—bone cancer	7.06e-05	0.000669	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NDUFA12—bone cancer	6.94e-05	0.000658	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TGFBR2—bone cancer	6.86e-05	0.000651	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—IGF1R—bone cancer	6.64e-05	0.00063	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TGFBR2—bone cancer	6.61e-05	0.000627	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—GNA11—bone cancer	6.58e-05	0.000624	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—ATF1—bone cancer	6.58e-05	0.000624	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—IGF1R—bone cancer	6.46e-05	0.000612	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IL3—bone cancer	6.42e-05	0.000608	CbGpPWpGaD
Aminophylline—PDE3A—Hemostasis—TP53—bone cancer	6.24e-05	0.000592	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—IGF1R—bone cancer	6.22e-05	0.00059	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—ATF1—bone cancer	6.12e-05	0.00058	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IL3—bone cancer	5.96e-05	0.000566	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—NT5C3A—bone cancer	5.75e-05	0.000545	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TGFBR2—bone cancer	5.49e-05	0.00052	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NDUFA12—bone cancer	5.36e-05	0.000508	CbGpPWpGaD
Aminophylline—HDAC2—Disease—KIT—bone cancer	5.35e-05	0.000507	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—KIT—bone cancer	5.3e-05	0.000503	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—IGF1R—bone cancer	5.16e-05	0.00049	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	5.1e-05	0.000484	CbGpPWpGaD
Aminophylline—HDAC2—Disease—BRAF—bone cancer	5.03e-05	0.000477	CbGpPWpGaD
Aminophylline—HDAC2—Hemostasis—TP53—bone cancer	4.99e-05	0.000473	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—BRAF—bone cancer	4.98e-05	0.000473	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling by GPCR—EGFR—bone cancer	4.83e-05	0.000458	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—KIT—bone cancer	4.81e-05	0.000457	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—IGF1R—bone cancer	4.8e-05	0.000455	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—KIT—bone cancer	4.68e-05	0.000444	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—BRAF—bone cancer	4.53e-05	0.000429	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—KIT—bone cancer	4.51e-05	0.000428	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—NT5C3A—bone cancer	4.44e-05	0.000421	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—BRAF—bone cancer	4.4e-05	0.000418	CbGpPWpGaD
Aminophylline—PDE4A—Signaling by GPCR—EGFR—bone cancer	4.39e-05	0.000416	CbGpPWpGaD
Aminophylline—PDE3A—Signaling by GPCR—EGFR—bone cancer	4.27e-05	0.000405	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—BRAF—bone cancer	4.24e-05	0.000402	CbGpPWpGaD
Aminophylline—HDAC2—Disease—MDM2—bone cancer	4.21e-05	0.000399	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—ENO2—bone cancer	4.19e-05	0.000397	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MDM2—bone cancer	4.18e-05	0.000396	CbGpPWpGaD
Aminophylline—ADORA1—Signaling by GPCR—EGFR—bone cancer	4.11e-05	0.00039	CbGpPWpGaD
Aminophylline—HDAC2—Disease—PTGS2—bone cancer	4.06e-05	0.000385	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—DHFR—bone cancer	3.89e-05	0.000369	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MDM2—bone cancer	3.79e-05	0.00036	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—KIT—bone cancer	3.74e-05	0.000355	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MDM2—bone cancer	3.69e-05	0.00035	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GNA11—bone cancer	3.63e-05	0.000345	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—JUN—bone cancer	3.63e-05	0.000344	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MDM2—bone cancer	3.55e-05	0.000337	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—MMP9—bone cancer	3.53e-05	0.000335	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—BRAF—bone cancer	3.52e-05	0.000334	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—KIT—bone cancer	3.48e-05	0.00033	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—JUN—bone cancer	3.3e-05	0.000313	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—CYP3A4—bone cancer	3.29e-05	0.000312	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—BRAF—bone cancer	3.27e-05	0.00031	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—MMP9—bone cancer	3.21e-05	0.000304	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—JUN—bone cancer	3.21e-05	0.000304	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling by GPCR—EGFR—bone cancer	3.17e-05	0.000301	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—MMP9—bone cancer	3.12e-05	0.000296	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—JUN—bone cancer	3.09e-05	0.000293	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—MMP9—bone cancer	3e-05	0.000285	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MDM2—bone cancer	2.95e-05	0.00028	CbGpPWpGaD
Aminophylline—HDAC2—Disease—EGFR—bone cancer	2.88e-05	0.000273	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—EGFR—bone cancer	2.85e-05	0.000271	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—GSTP1—bone cancer	2.82e-05	0.000267	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MDM2—bone cancer	2.74e-05	0.00026	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—EGFR—bone cancer	2.59e-05	0.000246	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—JUN—bone cancer	2.56e-05	0.000243	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—EGFR—bone cancer	2.52e-05	0.000239	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—ENO2—bone cancer	2.52e-05	0.000239	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—MMP9—bone cancer	2.49e-05	0.000237	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—EGFR—bone cancer	2.43e-05	0.00023	CbGpPWpGaD
Aminophylline—ADORA2B—Signaling Pathways—TP53—bone cancer	2.4e-05	0.000227	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—JUN—bone cancer	2.38e-05	0.000226	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—DHFR—bone cancer	2.34e-05	0.000222	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—MMP9—bone cancer	2.32e-05	0.00022	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GNA11—bone cancer	2.18e-05	0.000207	CbGpPWpGaD
Aminophylline—PDE4A—Signaling Pathways—TP53—bone cancer	2.18e-05	0.000206	CbGpPWpGaD
Aminophylline—PDE3A—Signaling Pathways—TP53—bone cancer	2.12e-05	0.000201	CbGpPWpGaD
Aminophylline—ADORA1—Signaling Pathways—TP53—bone cancer	2.04e-05	0.000193	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—EGFR—bone cancer	2.02e-05	0.000191	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000188	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.97e-05	0.000187	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—ENO2—bone cancer	1.94e-05	0.000184	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—EGFR—bone cancer	1.87e-05	0.000178	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—DHFR—bone cancer	1.8e-05	0.000171	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000161	CbGpPWpGaD
Aminophylline—HDAC2—Signaling Pathways—TP53—bone cancer	1.69e-05	0.00016	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GNA11—bone cancer	1.69e-05	0.00016	CbGpPWpGaD
Aminophylline—ADORA2A—Signaling Pathways—TP53—bone cancer	1.57e-05	0.000149	CbGpPWpGaD
Aminophylline—CYP2E1—Metabolism—PTGS2—bone cancer	1.46e-05	0.000138	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—GSTP1—bone cancer	1.31e-05	0.000124	CbGpPWpGaD
Aminophylline—CYP1A2—Metabolism—PTGS2—bone cancer	8.77e-06	8.32e-05	CbGpPWpGaD
Aminophylline—CYP3A4—Metabolism—PTGS2—bone cancer	6.77e-06	6.42e-05	CbGpPWpGaD
